Prostate cancer screening involves testing for early signs of prostate cancer in asymptomatic men, primarily using the prostate-specific antigen (PSA) blood test and digital rectal examination (DRE). The decision to undergo screening should be based on a discussion between the patient and healthcare provider, considering the potential benefits and harms, including false positives, overdiagnosis, and overtreatment.